VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: Effects of dietary fructose alone or in combination with pioglitazone

Diabetes

Volumn 45, Issue 6, 1996, Pages 806-811

  Kazumi, Tsutomu ^b,f   Hirano, Tsutomu ^c   Odaka, Hiroyuki ^d   Ebara, Tetsu ^c   Amano, Nobuyuki ^d   Hozumi, Toshiki ^a   Ishida, Yoshihiko ^a   Yoshino, Gen ^e  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b Hyogo Rehabilitation Center Hospital   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f Hyogo Rehabilitation Center Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; INSULIN; PIOGLITAZONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; GENETIC MODEL; GLUCOSE BLOOD LEVEL; HALF LIFE TIME; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INTRAGASTRIC DRUG ADMINISTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0029931409     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.806     Document Type: Article

References (32)

1. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
2. Hwang IS, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 10:512-516, 1987
3. Tobey TA, Mondon CE, Azvaroni I, Reaven GM: Mechanism of insulin resistance in fructose-fed rats. Metabolism 31:608-612, 1982
4. Yoshino G, Matsushita M, Maeda E, Naka Y, Nagata K, Morita M, Matsuba K, Kazumi T, Kasuga M: Effect of long-term insulin deficiency and insulin treatment on the composition of triglyceride-rich lipoproteins and triglyceride turnover in rats. Atherosclerosis 92:243-250, 1992
5. Yoshino G, Matsushita M, Iwai M, Morita M, Matsuba K, Nagata K, Maeda E, Furukawa S, Hirano T, Kazumi T: Effect of mild diabetes and dietary fructose on VLDL triglyceride turnover in rats. Metabolism 41:236-240, 1992
6. Kazumi T, Vranic M, Steiner G: Triglyceride kinetics: effects of dietary glucose, sucrose or fructose alone or with hyperinsulinemia. Am J Physiol 250:E325-E330, 1986
7. Kazumi T, Yoshino G, Matsuba K, Iwai M, Iwatani I, Matsushita M, Kasama T, Hosokawa T, Numano F, Baba S: Effects of dietary glucose or fructose or the secretion rate and particle size of triglyceride-rich lipoproteins in Zucker fatty rats. Metabolism 40:962-966, 1991
8. Hirano T, Mamo JL, Poapst ME, Kuksis A, Steiner G: Impaired very low-density lipoprotein-triglyceride catabolism in acute and chronic fructose-fed rats. Am J Physiol 256:E559-E565, 1989
9. Mamo JL, Hirano T, James L, Szeto L, Steiner G: Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism. Metabolism 40:888-893, 1991
10. Iwanishi M, Kobayashi M: Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats. Metabolism 42:1017-1021, 1993
11. Kraegen EW, James DE, Jenkins AB, Chisholm DJ, Storlien LH: A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. Metabolism 38:1089-1093, 1989
12. Kobayashi M, Iwanishi M, Egawa K, Shigeta Y: Pioglitazone increases insulin sensitivity by activating kinase of insulin receptors. Diabetes 41:476-483, 1992
13. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558, 1988
14. Stevenson RW, Hutson NJ, Krupp MN, Volkmann RA, Holland GF, Eggler JF, Clark DA, McPherson RK, Hall KL, Danbury BH, Gibbs EM, Kreutter DK: Actions of novel antidiabetic agent englitazone in hyperglycemic ob/ob mice. Diabetes 39:1218-1227, 1990
15. Ikeda H, Takemori S, Sugiyama Y, Shimura Y, Sohda T, Megura K, Fujita T: Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim Forchung 40:156-162, 1990
16. Ikeda H, Shino A, Matsuo T, Iwatsuka H, Suzuoki Z: A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes 30:1045-1050, 1981
17. Yoshino G, Hirano T, Nagata K, Maeda E, Naka Y, Murata Y, Kazumi T, Kasuga M: Hypertriglycemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor. J Lipid Res 34:875-884, 1993
18. Bird M, Williams MA, Baker N: Triglycerol secretion in rats: validation of a tracer method employing radioactive glycerol. J Nutr 114:1978-1985, 1984
19. Furukawa S, Hirano T, Namo JCL, Nagano S, Takahashi T: Catabolic defect of triglyceride is associated with abnormal very-low density lipoprotein in experimental nephrosis. Metabolism 39:101-107, 1990
20. Reaven EP, Reaven GM: Mechanism of development of diabetic hypertriglyceridemia in streptozotocin-treated rats: effect of diet and duration of insulin deficiency. J Clin Invest 54:1167-1178, 1974
21. Yoshino G, Iwai M, Kazumi T, Matsushita M, Morita M, Iwatani I, Baba S: Effect of dietary fructose on triglyceride turnover in streptozotocin-diabetic rats. Atherosclerosis 79:41-46, 1989
22. Gutman A, Shafrir E: Adipose tissue in experimental nephrotic syndrome. Am J Physiol 205:702-706, 1983
23. Nakai T, Yamada T, Tamai T, Kobayashi T, Hayashi T, Takada R: The effects of streptozotocin diabetes on hepatic triglyceride lipase activity in the rats. Metabolism 28:30-40, 1979
24. Belfrage P, Vaughan M: Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J Lipid Res 10:341-344, 1969
25. Nilsson-Ehle P, Schotz MC: A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17:536-541, 1976
26. Duncan DB: Multiple range and multiple F test. Biometrics 11:1-42, 1955
27. Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T: Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arzneim Forschung 40:263-267, 1990
28. Palmer J, Cooper C, Shipley RA: Rate of release of hepatic triacylglycerol into serum in the starved rat. Biochem J 172:219-226, 1978
29. Kinnuner PKJ, Virtanen JA, Vainio P: Lipoprotein and hepatic endothelial lipase: their roles in plasma lipoprotein metabolism. Atherosclerosis Rev 11:65-105, 1983
30. Sugiyama Y, Shimura Y, Ikeda H: Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneim Forshung 40:436-440, 1990
31. Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD: Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant rhesus monkeys. Diabetes 43:204-211, 1994
32. Brunzell JD, Hazzard WR, Porte D, Bierman EL: Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in men. J Clin invest 52:1578-1585, 1973